Results 171 to 180 of about 117,497 (280)

Immune Checkpoint Inhibitors and Immunomodulators for Cancer Immunotherapy: Insights Into Resistance and Therapeutic Strategies

Advanced Science, Volume 13, Issue 25, 4 May 2026.
The schematic diagram illustrates the roles of novel immune checkpoints, immunomodulatory factors, cell death and multimodal technologies in cancer immunotherapy. Abstract Cancer immunotherapy has redefined cancer treatment. However, the molecular and cellular basis of immune evasion and therapeutic resistance remains incompletely understood.
Fangquan Chen, Yang Yu, Xiutao Cai, Junhao Lin, Ruirui Liang, Rui Kang, Daolin Tang, Jiao Liu   +7 more
wiley   +1 more source

Dueling Malignancies: A Rare Case of Concurrent Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML) in a Multimorbid Elderly Patient. [PDF]

Cureus
Alzahim M, Alakedi A, Almugren O, Khoja O, Alias N, Abdelgader A.   +5 more
europepmc   +1 more source

Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript.

Blood, 1990
L. Selleri, M. Lindern, A. Hermans, D. Meijer, G. Torelli, G. Grosveld   +5 more
semanticscholar   +1 more source

Evaluation of the Effects of 50 Hz Magnetic Field Exposure on the Human Hematopoietic System in Humanized Mice

Bioelectromagnetics, Volume 47, Issue 4, May 2026.
ABSTRACT Accumulating evidence from experimental animal studies is essential for clarifying the causal relationship between exposure to power‐frequency magnetic fields (MFs) and childhood leukemia. In this study, we developed a 50 Hz MF exposure system for experimental animals.
Masayuki Takahashi, Izumi Nishimura, Toshihiko Toda   +2 more
wiley   +1 more source

From Molecular Silence to Lymphoid Blast Phase: Diagnostic and Therapeutic Challenges in a Young Female Patient With Chronic Myeloid Leukemia. [PDF]

Cureus
Alqallaf ZH, Atwa S.
europepmc   +1 more source

Tumor Anti‐Angiogenesis Therapy and Its Influence on Immune Cell Function in the Tumor Microenvironment

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Vascular normalization, one promising anti‐angiogenic strategy, has the potential to enhance vascular perfusion and elevate the infiltration of immune cells into tumors by rectifying aberrant tumor blood vessels. This results in the enhancement of immunotherapy.
Yu Tang, Yuyan Ding, LiPing Wang, Yujiao Yang, Youwei Han, Peng Zhou, Huiheng Qu, Kaiyuan Deng, Jiazeng Xia   +8 more
wiley   +1 more source

Chronic myeloid leukemia in blast phase masquerading as T-lymphoblastic lymphoma with t(22;22) karyotype: a case report. [PDF]

Front Oncol
Liu Y, Hao Z, Bai J, Zhou W, Zhang H, Guan Z, Zhang L, Li L.   +7 more
europepmc   +1 more source

GATA2 Mutations Predict Poor Prognosis in Transplanted Myeloid Neoplasms

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background GATA binding protein 2 (GATA2) plays a crucial role in the differentiation, proliferation, and maintenance of hematopoietic stem cells (HSCs). GATA2 mutations have been identified in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), but the impact of somatic GATA2 mutations on prognosis remains controversial ...
Xian Zhang, Bingjie Wang, Yujun Dong, Qingya Wang, Qian Wang, Jialin Zhu, Qingyun Wang, Na Han, Yuan Li   +8 more
wiley   +1 more source

CD19-negative relapse after CAR-T cell therapy: mechanisms of antigen escape and lineage switch. [PDF]

Front Immunol
Huang J, Huang X, Yu D.
europepmc   +1 more source

Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.

Blood, 2007
B. Wouters, M. A. Jordà, Karen Keeshan, Irene Louwers, Claudia A. J. Erpelinck-Verschueren, D. Tielemans, A. Langerak, Yiping He, Yumi Yashiro‐Ohtani, Pu Zhang, C. Hetherington, R. Verhaak, P. Valk, B. Löwenberg, D. Tenen, W. Pear, R. Delwel   +16 more
semanticscholar   +1 more source